Inactivated rabies vaccine - Liaoning ChengDa Biotechnology

Drug Profile

Inactivated rabies vaccine - Liaoning ChengDa Biotechnology

Alternative Names: Chromatographically purified rabies vaccine - Liaoning ChengDa Biotechnology; Perfusion cell culture based rabies vaccine - Liaoning ChengDa Biotechnology; Purified Vero cell rabies vaccine - Liaoning ChengDa Biotechnology; PVRV - Liaoning ChengDa Biotechnology; SPEEDA; TRCS CPRV - Liaoning ChengDa Biotechnology; TRCS SPEEDA; Vero cell derived rabies vaccine - Liaoning ChengDa Biotechnology

Latest Information Update: 15 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Liaoning ChengDa Biotechnology
  • Developer Biovalys; Liaoning ChengDa Biotechnology; Thai Red Cross Society
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rabies

Most Recent Events

  • 04 Dec 2014 Registered for Rabies (In children, Prevention, In adults) in India, Nepal, Pakistan, Georgia, Belarus, Kenya (Intradermal) before November 2014
  • 04 Dec 2014 Registered for Rabies (In children, Prevention, In adults) in India, Nepal, Pakistan, Georgia, Belarus, Kenya (IM) before November 2014
  • 17 Apr 2013 Launched for Rabies (In children, Prevention, In adults) in Thailand (IM) before April 2013
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top